CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
Frequently asked questions
What sector does CMG Pharmaceutical Co. Ltd (058820) operate in?
CMG Pharmaceutical Co. Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is CMG Pharmaceutical Co. Ltd (058820) current stock price?
As of the latest data, CMG Pharmaceutical Co. Ltd stock price is ₩671, with a previous close of ₩671.
What is CMG Pharmaceutical Co. Ltd (058820) current market capitalization?
CMG Pharmaceutical Co. Ltd market cap is approximately 99.20 billion.
Does CMG Pharmaceutical Co. Ltd (058820) pay dividends?
No. CMG Pharmaceutical Co. Ltd does not pay a dividend.
What is CMG Pharmaceutical Co. Ltd (058820) beta (volatility) score?
CMG Pharmaceutical Co. Ltd has a beta of 0.469, indicating lower volatility than the overall market.
